Clinical trials
Phase 1 Muscular Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arcellx, Inc. | 1 |
| AstraZeneca | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| IGM Biosciences, Inc. | 1 |
| Johns Hopkins University | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Northwestern University | 1 |
| PepGen Inc | 1 |
| RyCarma Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Diseases | 9 |
| Musculoskeletal Diseases | 4 |
| Nervous System Diseases | 4 |
| Neuromuscular Diseases | 4 |
| Myositis | 3 |
| Genetic Diseases, Inborn | 2 |
| Muscular Disorders, Atrophic | 2 |
| Muscular Dystrophies | 2 |
| Arthritis | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.